Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A kind of traditional Chinese medicine composition for treating pulmonary fibrosis and its application

A technology of pulmonary interstitial fibrosis and composition, which is applied in the field of traditional Chinese medicine composition for the treatment of pulmonary fibrosis, can solve problems that have not been reported, and achieve pain relief, scientifically advanced preparation methods, and remarkable effects

Active Publication Date: 2021-08-31
SHUGUANG HOSPITAL AFFILIATED WITH SHANGHAI UNIV OF T C M
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] About a kind of Chinese medicine composition for the treatment of pulmonary fibrosis of the present invention and its application, there is no report yet

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of traditional Chinese medicine composition for treating pulmonary fibrosis and its application
  • A kind of traditional Chinese medicine composition for treating pulmonary fibrosis and its application
  • A kind of traditional Chinese medicine composition for treating pulmonary fibrosis and its application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0048] Embodiment 1 Chinese medicine composition (one)

[0049] The raw materials are taken according to the following proportions by weight: 35 parts of raw land, 8 parts of cornus, 8 parts of Ligustrum lucidum, 8 parts of Achyranthes bidentata, 8 parts of dodder seed, 4 parts of Schisandra chinensis, 1 part of gecko, 4 parts of tangerine, loofah 4 parts of network, 1 part of Panax notoginseng powder.

Embodiment 2

[0050] Embodiment 2 Chinese medicine composition (two)

[0051] The raw materials are taken according to the following proportions by weight: 55 parts of raw land, 28 parts of cornus, 28 parts of Ligustrum lucidum, 28 parts of Achyranthes bidentata, 28 parts of dodder fruit, 14 parts of Schisandra chinensis, 5 parts of gecko, 14 parts of tangerine, loofah 14 parts of network, 5 parts of Panax notoginseng powder.

Embodiment 3

[0052] Embodiment 3 Chinese medicine composition (three)

[0053] The raw materials are taken according to the following proportions by weight: 35 parts of raw land, 28 parts of cornus, 8 parts of Ligustrum lucidum, 28 parts of Achyranthes bidentata, 8 parts of dodder seed, 14 parts of Schisandra chinensis, 1 part of gecko, 14 parts of tangerine, loofah 4 parts of network, 5 parts of Panax notoginseng powder.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the technical field of traditional Chinese medicine, in particular to a traditional Chinese medicine composition for treating pulmonary fibrosis and its application. The traditional Chinese medicine composition is made of the following raw materials in parts by weight: 18 parts of Zhenzi, 18 parts of Achyranthes bidentata, 18 parts of Cuscuta, 9 parts of Schisandra, 3 parts of Gecko, 9 parts of Tangerine, 9 parts of loofah, and 3 parts of Panax notoginseng powder. The invention also includes the application of the traditional Chinese medicine composition in the preparation of medicine for treating pulmonary fibrosis. Its advantage is shown in: 1, preferably each raw material medicine and the proportioning therebetween, clinical test result shows, Chinese medicine composition of the present invention can significantly resist pulmonary fibrosis, be used for the treatment of pulmonary interstitial fibrosis, have remarkable effect advantage. Animal experiments show that the traditional Chinese medicine composition of the present invention can improve model rat pulmonary fibrosis by promoting autophagy. 2. Each crude drug of the present invention conforms to the compatibility principle of "jun, minister, assistant and envoy", and has the effects of invigorating the kidney and nourishing qi, dredging collaterals and eliminating numbness.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicines, in particular to a traditional Chinese medicine composition for treating pulmonary fibrosis and its application. Background technique [0002] Pulmonary fibrosis is the end-stage change of a large class of lung diseases characterized by fibroblast proliferation and accumulation of a large amount of extracellular matrix, accompanied by inflammatory damage and tissue structure destruction, that is, normal alveolar tissue is damaged and undergoes abnormal repair to lead to structural changes. Abnormal (scarring). The cause of most patients with pulmonary fibrosis is unknown (idiopathic). This group of diseases is called idiopathic interstitial pneumonia (IIP), which is a large category of interstitial lung diseases. Among idiopathic interstitial pneumonia (IIP), the most common disease type with pulmonary fibrosis as the main manifestation is idiopathic pulmonary fibrosis (IPF...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/804A61P11/00A61K35/583
CPCA61K35/583A61K36/21A61K36/258A61K36/39A61K36/40A61K36/42A61K36/43A61K36/57A61K36/638A61K36/752A61K36/79A61K36/804A61K2236/331A61K2236/39A61P11/00A61K2300/00
Inventor 张炜张兴
Owner SHUGUANG HOSPITAL AFFILIATED WITH SHANGHAI UNIV OF T C M
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com